TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
548,490
|
643,462
|
533,125 |
| Financial expenses |
33,622
|
15,031
|
27,038 |
| Earnings before taxes |
24,673
|
28,022
|
32,285 |
| EBITDA |
82,127
|
82,745
|
95,536 |
| Total assets |
1,823,948
|
1,706,909
|
1,342,796 |
| Current assets |
844,278
|
700,579
|
363,339 |
| Current liabilities |
531,714
|
458,604
|
201,164 |
| Equity capital |
1,273,003
|
1,231,486
|
1,128,983 |
| - share capital |
327,113
|
321,319
|
300,030 |
| Employees (average) |
370
|
345
|
364 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.8%
|
72.1%
|
84.1% |
| Turnover per employee |
1,482
|
1,865
|
1,465 |
| Profit as a percentage of turnover |
4.5%
|
4.4%
|
6.1% |
| Return on assets (ROA) |
3.2%
|
2.5%
|
4.4% |
| Current ratio |
158.8%
|
152.8%
|
180.6% |
| Return on equity (ROE) |
1.9%
|
2.3%
|
2.9% |
| Change turnover |
-106,573
|
72,508
|
67,603 |
| Change turnover % |
-16%
|
13%
|
15% |
| Chg. No. of employees |
25
|
-19
|
14 |
| Chg. No. of employees % |
7%
|
-5%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.